ArticlePloS one2023

NAV-001, a high-efficacy antibody-drug conjugate targeting mesothelin with improved delivery of a potent payload by counteracting MUC16/CA125 inhibitory effects.

Nicholas C Nicolaides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.